AU716125B2 - Prophylactic and therapeutic treatment of skin sensitization and irritation - Google Patents

Prophylactic and therapeutic treatment of skin sensitization and irritation Download PDF

Info

Publication number
AU716125B2
AU716125B2 AU33727/97A AU3372797A AU716125B2 AU 716125 B2 AU716125 B2 AU 716125B2 AU 33727/97 A AU33727/97 A AU 33727/97A AU 3372797 A AU3372797 A AU 3372797A AU 716125 B2 AU716125 B2 AU 716125B2
Authority
AU
Australia
Prior art keywords
skin
agent
adverse
agents
phenoxyacetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33727/97A
Other languages
English (en)
Other versions
AU3372797A (en
Inventor
John J Wille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU3372797A publication Critical patent/AU3372797A/en
Application granted granted Critical
Publication of AU716125B2 publication Critical patent/AU716125B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU33727/97A 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation Ceased AU716125B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/670201 1996-06-21
US08/670,201 US5716987A (en) 1996-06-21 1996-06-21 Prophylactic and therapeutic treatment of skin sensitization and irritation
PCT/US1997/009318 WO1997048369A2 (en) 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation

Publications (2)

Publication Number Publication Date
AU3372797A AU3372797A (en) 1998-01-07
AU716125B2 true AU716125B2 (en) 2000-02-17

Family

ID=24689424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33727/97A Ceased AU716125B2 (en) 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation

Country Status (7)

Country Link
US (2) US5716987A (enExample)
EP (1) EP0954300A4 (enExample)
JP (1) JP2000512996A (enExample)
AU (1) AU716125B2 (enExample)
CA (1) CA2258736A1 (enExample)
NZ (1) NZ333324A (enExample)
WO (1) WO1997048369A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
US7030133B2 (en) * 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6337350B1 (en) 1999-04-05 2002-01-08 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
AU1773601A (en) * 1999-11-18 2001-05-30 John D. Bolla Treatment or prevention of photoaging and skin cancer
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
AU2004287434B2 (en) * 2003-10-27 2011-04-07 City Of Hope Methods of lowering lipid levels in a mammal
CA2567437A1 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020102695A1 (en) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Thermally regulated transdermal drug delivery system
US11865602B2 (en) * 2020-01-16 2024-01-09 Ehc Inc. Paintless dent removal tool, system and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383662A1 (fr) * 1977-03-15 1978-10-13 Cassenne Lab Sa Nouvelles compositions a usage cosmetique
JPS55133304A (en) * 1979-04-05 1980-10-17 Shiseido Co Ltd Perfume controller
US4524214A (en) * 1983-11-03 1985-06-18 Stauffer Chemical Company Process for forming esters of glyoxylic acids
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
DE4225794C2 (de) * 1992-07-31 1994-12-08 Schuelke & Mayr Gmbh Tb-wirksame Carbonsäuren

Also Published As

Publication number Publication date
US6670395B1 (en) 2003-12-30
JP2000512996A (ja) 2000-10-03
NZ333324A (en) 2000-08-25
EP0954300A2 (en) 1999-11-10
US5716987A (en) 1998-02-10
EP0954300A4 (en) 2004-10-20
WO1997048369A2 (en) 1997-12-24
AU3372797A (en) 1998-01-07
CA2258736A1 (en) 1997-12-24
WO1997048369A3 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
AU716125B2 (en) Prophylactic and therapeutic treatment of skin sensitization and irritation
AU708644B2 (en) Prophylactic and therapeutic treatment of skin sensitization and irritation
MXPA97003694A (en) Profilactico and therapeutic treatment of the sensitization and irritation of the p
US5665378A (en) Transdermal therapeutic formulation
US5618557A (en) Prophylactic treatment of allergic contact dermatitis
EP1248613B1 (en) Clonidine preparations
Mehta Topical and transdermal drug delivery: what a pharmacist needs to know
MXPA97003693A (en) Profilactic treatment of allergic dermatitis by conta
SK284135B6 (sk) Podstatne homogénny tekutý prostriedok na perkutánne podávanie aktívnych látok a spôsob perkutánneho podávania
Lebwohl et al. Topical therapy for psoriasis.
JPH11502513A (ja) 糖尿病性ニューロパシーの処置方法
JP2725776B2 (ja) コルチコステロイドと感作性薬物との同時投与による接触アレルギーの予防
WO1997018782A1 (en) Treatment with calcium channel blockers for drug-induced hypersensitivity
JPH01299217A (ja) 硬膏剤
CN112891242A (zh) 一种用于祛斑美白抗炎的组合物及其应用
JPH1180031A (ja) 外用剤及び経皮又は経粘膜吸収性を増進する方法
AU2001287706B2 (en) Treatment of burns
AU2001287706A1 (en) Treatment of burns
CA2003608A1 (en) Application of medications to painful skin
HK1050484B (en) Clonidine preparations
IE83245B1 (en) Treatment of burns
JPH04210628A (ja) 炎症性皮膚疾患治療用の外用剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)